in this issue
Regions :: Western Europe :: Sweden
Roche Sells Four Products to Swedish Firm for €120 million
2:25 AM MDT | August 15, 2008 | Deepti Ramesh
Roche says it has signed an agreement to sell four of its pharmaceutical products to specialty pharmaceutical company Meda (Solna, Sweden). The worldwide product rights are being sold for a total of €120 million, and the transaction is expected to close by the end of the year, Roche says. The acquired products, which include an anticoagulant, a loop diuretic, a drug for the treatment of painful inflammatory and degenerative disorders, and an antidepressant, have strong brand names and a total sales of about SEK 500 million ($80 million), Meda says. The most...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: